Microarray-based DNA methylation study of Ewing's sarcoma of the bone

Oncology Letters

Volumn 8, Issue 4, 2014, Pages 1613-1617

  Park, Hye Rim ^a   Jung, Woon Won ^b   Kim, Hyun Sook ^c   Park, Yong Koo ^d  

^a Hallym University   (South Korea)

^b Chongju University   (South Korea)

^c Korea University   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

Author keywords

DNA methylation; Ewing's sarcoma; Microarray

Indexed keywords

APC PROTEIN; GROWTH DIFFERENTIATION FACTOR 10; LEUKEMIA INHIBITORY FACTOR RECEPTOR; TRANSCRIPTION FACTOR HOXA10;

ADOLESCENT; ADULT; AGGRESSION; ARTICLE; CELL ADHESION; CELL CYCLE REGULATION; CELL MATURATION; CHILD; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DNA METHYLATION ASSAY; DNA MICROARRAY; EWING SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN SYNTHESIS REGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WORLD HEALTH ORGANIZATION;

EID: 84931565820     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2322     Document Type: Article

References (29)

1. Esteller M: Epigenetics in cancer. N Engl J Med 358: 1148-1159, 2008.
2. Kang GH: CpG island hypermethylation in gastric carcinoma and its premalignant lesions. Korean J Pathol 46: 1-9, 2012.
3. Esteller M, Com PG, Baylin SB and Herman JG: A gene hypermethylation profile of human cancer. Cancer Res 61: 3225-3229, 2001.
4. Suzuki H, Watkins DN, Jair KW, et al: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36: 417-422, 2004.
5. Ushijima T: Detection and interpretation of altered methylation patterns in cancer cells. Nat Rev Cancer 5: 223-231, 2005.
6. Tsuchiya T, Sekine K, Hinohara S, Namiki T, Nobori T and Kaneko Y: Analysis of the p16INK4, p14ARF, p15, TP53, and MDM2 genes and their prognostic implications in osteosarcoma and Ewing sarcoma. Cancer Genet Cytogenet 120: 91-98, 2000.
7. Hoque MO, Kim MS, Ostrow KL, et al: Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 68: 2661-2670, 2008.
8. Bibikova M, Lin Z, Zhou L, et al: High-throughput DNA methylation profiling using universal bead arrays. Genome Res 16: 383-393, 2006.
9. Lin Z, Thomas NJ, Bibikova M, et al: DNA methylation markers of surfactant proteins in lung cancer. Int J Oncol 31: 181-191, 2007.
10. Bibikova M, Chudin E, Wu B, et al: Human embryonic stem cells have a unique epigenetic signature. Genome Res 16: 1075-1083, 2006.
11. Bjornsson HT, Brown LJ, Fallin MD, et al: Epigenetic specificity of loss of imprinting of the IGF2 gene in Wilms tumors. J Natl Cancer Inst 99: 1270-1273, 2007.
12. de Alvia E, Lessnick SL and Sorensen PH: Ewing sarcoma. In: WHO Classification of Tumors of Soft Tissue and Bone. Fletcher CDM, Bridge JA, Hogendoorn PCW and Mertens F (eds). IARC Press, Lyon, pp305-310, 2013.
13. Kim GY, Park JH, Kim YW, Jung WW, Unni KK and Park YK: Absence of amplification of HER-2/neu (c-erbB-2) gene in Ewing's sarcoma: a real-time polymerase chain reaction method. Pathol Res Pract 200: 663-667, 2004.
14. Farrand K, Jovanovic L, Delahunt B, et al: Loss of heterozygosity studies revisited: prior quantification of the amplifiable DNA content of archival samples improves efficiency and reliability. J Mol Diagn 4: 150-158, 2002.
15. Bibikova M and Fan JB: GoldenGate assay for DNA methylation profiling. Methods Mol Biol 507: 149-163, 2009.
16. Khoury JD: Ewing sarcoma family of tumors. Adv Anat Pathol 12: 212-220, 2005.
17. Fulda S, Küfer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B and Debatin KM: Sensitization for death receptor-or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865-5877, 2001.
18. López-Guerrero JA, Pellín A, Noguera R, Carda C and Llombart-Bosch A: Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors. Lab Invest 81: 803-814, 2001.
19. Rathi A, Virmani AK, Harada K, et al: Aberrant hypermethylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms. Clin Cancer Res 9: 3674-3678, 2003.
20. Martín-Subero JI, Kreuz M, Bibikova M, et al;Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe: New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling. Blood 113: 2488-2497, 2009.
21. Serao NV, Delfino KR, Southey BR, Beever JE and Rodriguez-Zas SL: Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics 4: 49, 2011.
22. Giovannini M, Selleri L, Hermanson GG and Evans GA: Localization of the human oncostatin M gene (OSM) to chromosome 22q12, distal to the Ewing's sarcoma breakpoint. Cytogenet Cell Genet 62: 32-34, 1993.
23. Weiss TW, Simak R, Kaun C, et al: Oncostatin M and IL-6 induce u-PA and VEGF in prostate cancer cells and correlate in vivo. Anticancer Res 31: 3273-3278, 2011.
24. Ignatov A, Bischoff J, Ignatov T, et al: APC promoter hypermethylation is an early event in endometrial tumorigenesis. Cancer Sci 101: 321-327, 2010.
25. Shu Y, Wang B, Wang J, Wang JM and Zou SQ: Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World J Gastroenterol 17: 3407-3419, 2011.
26. Fiegl H, Windbichler G, Mueller-Holzner E, et al: HOXA11 DNA methylation-a novel prognostic biomarker in ovarian cancer. Int J Cancer 123: 725-729, 2008.
27. Avigad S, Shukla S, Naumov I, et al: Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma. Pediatr Blood Cancer 53: 1023-1028, 2009.
28. Harada K, Toyooka S, Maitra A, et al: Aberrant promoter hypermethylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 21: 4345-4349, 2002.
29. Garcia-Manero G: Demethylating agents in myeloid malignancies. Curr Opin Oncol 20: 705-710, 2008.